Analysis enhancement can be described as a perceived enhancement of one's overall ability to process information and logically or creatively analyse concepts, ideas and scenarios. The experience of this effect can lead to deep and complex states of contemplation which often results in an abundance of new and insightful ideas. This can give the person a perceived ability to analyze concepts and problems in a manner which allows them to gain inspiration or reach new conclusions, perspectives, and solutions which would have been otherwise difficult to conceive of.
This effect is consistently triggered in a mild form by substances such as stimulants and nootropics. However, psychedelics in particular often manifest this effect in an extremely distinct form that synergizes with accompanying effects such as personal bias suppression in a manner which results in a deeply therapeutic and introspective state. This can result in newfound logical resolutions and personal acceptance regarding past events, the present situation, future possibilities, insecurities, fears, hopes, goals, struggles, and traumas. The experience of this state is extremely efficient at facilitating therapeutic self-improvement and positive personal growth on a level that remains largely unparalleled by that of everyday sober living.
In other cases, psychedelic analysis enhancement can lead into states which are not introspective but instead result in a deep analysis of the exterior world, both as a whole and as the things which comprise it. This can result in a perceived abundance of insightful ideas and conclusions with powerful themes pertaining to what is often described as "the bigger picture". These ideas generally involve (but are not limited to) insight into philosophy, science, spirituality, society, culture, universal progress, humanity, loved ones, the finite nature of our lives, history, the present moment and future possibilities.
Compounds which may cause this effect commonly include:
1P-ETH-LAD, 1P-LSD, 2-Aminoindane, 2-FA, 2-FMA, 2-Fluorodeschloroketamine, 25B-NBOH, 25B-NBOMe, 25C-NBOH, 25C-NBOMe, 25D-NBOMe, 25I-NBOH, 25I-NBOMe, 25N-NBOMe, 2C-B, 2C-C, 2C-D, 2C-E, 2C-I, 2C-P, 2C-T-2, 2C-T-7, 3,4-CTMP, 3-FA, 3-FMA, 3-FPM, 3-MeO-PCE, 3-MeO-PCMo, 3C-E, 4-AcO-DET, 4-AcO-DMT, 4-AcO-DiPT, 4-AcO-MET, 4-AcO-MiPT, 4-FMA, 4-HO-DET, 4-HO-DPT, 4-HO-MET, 4-HO-MiPT, 4-MeO-PCP, 4F-EPH, 4F-MPH, 5-APB, 5-MAPB, 5-MeO-DALT, 5-MeO-DMT, 5-MeO-DiBF, 5-MeO-MiPT, A-PHP, A-PVP, AL-LAD, ALD-52, Amphetamine, Ayahuasca, Bromantane, Bromo-DragonFLY, Bufotenin, Butylone, Caffeine, Cannabis, Cocaine, Creatine, DMT, DOB, DOC, DOI, DOM, Deschloroketamine, Desoxypipradol, Dichloropane, Diphenidine, ETH-CAT, ETH-LAD, Efavirenz, Ephenidine, Ethylone, Ethylphenidate, Hexedrone, Hexen, Ibogaine, Isopropylphenidate, Ketamine, LSA, LSD, LSZ, Lisdexamfetamine, Mescaline, Methamphetamine, Methiopropamine, MXE, Methylnaphthidate, Methylone, Methylphenidate, NEP, NM-2-AI, O-PCE, PCE, PCP, PRO-LAD, Pentedrone, Propylhexedrine, Psilocin, Psilocybin mushrooms, TMA-2, TMA-6, Theacrine, Theanine, Tyrosine, ΑMT
Documentation written by Josie Kins